信邦制药
(002390)
| 流通市值：70.01亿 | | | 总市值：74.45亿 |
| 流通股本：18.28亿 | | | 总股本：19.44亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 6,460,841,315.46 | 4,823,207,646.87 | 3,256,476,093.85 | 1,605,127,137.43 |
| 营业收入 | 6,460,841,315.46 | 4,823,207,646.87 | 3,256,476,093.85 | 1,605,127,137.43 |
| 二、营业总成本 | 6,029,956,602.6 | 4,470,734,285.09 | 3,032,948,961.52 | 1,535,323,707.21 |
| 营业成本 | 5,232,265,213.44 | 3,860,569,975.61 | 2,621,581,755.19 | 1,314,183,651.87 |
| 税金及附加 | 27,426,488.11 | 20,837,796.71 | 13,319,215.38 | 6,876,674.16 |
| 销售费用 | 343,414,000.78 | 254,852,297.29 | 173,661,310.75 | 85,664,834.87 |
| 管理费用 | 394,424,869.4 | 308,012,852.43 | 206,643,266.08 | 116,726,561.7 |
| 研发费用 | 4,672,953.58 | 2,047,197.9 | 1,666,146.84 | 691,393.55 |
| 财务费用 | 27,753,077.29 | 24,414,165.15 | 16,077,267.28 | 11,180,591.06 |
| 其中:利息费用 | 39,698,422.94 | 32,365,164.38 | 21,565,345.62 | 13,837,692.03 |
| 其中:利息收入 | 12,729,596.56 | 8,585,611.75 | 5,961,018.61 | 2,857,593.16 |
| 加:投资收益 | 9,397,367.33 | -788,943.67 | -2,033,937.67 | 4,566.25 |
| 资产处置收益 | 17,801.27 | -55,861.83 | -43,051.54 | -37,882.51 |
| 资产减值损失(新) | -7,523,015.71 | - | - | - |
| 信用减值损失(新) | -53,126,703.33 | -16,734,942.66 | -16,742,002.74 | 251,094.66 |
| 其他收益 | 5,382,978.6 | 4,954,859.81 | 4,053,699.54 | 1,100,465.53 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 385,033,141.02 | 339,848,473.43 | 208,761,839.92 | 71,121,674.15 |
| 加:营业外收入 | 25,010,364.72 | 2,364,102.15 | 1,459,020.11 | 1,217,905.71 |
| 减:营业外支出 | 14,021,913.7 | 6,511,746.7 | 1,398,758.17 | 150,047.94 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 396,021,592.04 | 335,700,828.88 | 208,822,101.86 | 72,189,531.92 |
| 减:所得税费用 | 42,249,086.61 | 32,255,423.11 | 17,224,732.35 | 9,541,011.22 |
| 六、净利润 | 353,772,505.43 | 303,445,405.77 | 191,597,369.51 | 62,648,520.7 |
| 持续经营净利润 | 353,772,505.43 | 303,445,405.77 | 191,597,369.51 | 62,648,520.7 |
| 归属于母公司股东的净利润 | 287,232,798.94 | 246,574,999.15 | 156,021,447.29 | 52,944,770.89 |
| 少数股东损益 | 66,539,706.49 | 56,870,406.62 | 35,575,922.22 | 9,703,749.81 |
| (一)基本每股收益 | 0.15 | 0.13 | 0.08 | 0.03 |
| (二)稀释每股收益 | 0.15 | 0.13 | 0.08 | 0.03 |
| 九、综合收益总额 | 353,772,505.43 | 303,445,405.77 | 191,597,369.51 | 62,648,520.7 |
| 归属于母公司股东的综合收益总额 | 287,232,798.94 | 246,574,999.15 | 156,021,447.29 | 52,944,770.89 |
| 归属于少数股东的综合收益总额 | 66,539,706.49 | 56,870,406.62 | 35,575,922.22 | 9,703,749.81 |
| 公告日期 | 2024-04-16 | 2023-10-30 | 2023-08-29 | 2023-04-29 |
| 审计意见(境内) | 标准无保留意见 | | | |